Orgenesis Inc.
General ticker "ORGS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $70.2M (TTM average)
Orgenesis Inc. does not follow the US Stock Market performance with the rate: -44.5%.
Estimated limits based on current volatility of 46.7%: low 0.29$, high 0.80$
Factors to consider:
- Total employees count: 146 (-12.6%) as of 2023
- Top business risk factors: Limited operating history of pocare business, No marketing/sales organization, Internal control weaknesses, Market competition, Regulatory and compliance
Short-term ORGS quotes
Long-term ORGS plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $35.50MM | $36.02MM | $0.53MM |
| Operating Expenses | $52.30MM | $44.63MM | $54.17MM |
| Operating Income | $-16.80MM | $-8.60MM | $-53.64MM |
| Non-Operating Income | $-1.15MM | $-3.36MM | $-10.81MM |
| Interest Expense | $0.00MM | $0.00MM | $2.17MM |
| R&D Expense | $0.00MM | $0.00MM | $11.09MM |
| Income(Loss) | $-17.95MM | $-11.96MM | $-64.44MM |
| Taxes | $0.11MM | $0.21MM | $-0.47MM |
| Profit(Loss)* | $-18.05MM | $-14.89MM | $-55.36MM |
| Stockholders Equity | $38.49MM | $27.56MM | $-20.98MM |
| Inventory | $0.12MM | $0.12MM | $0.03MM |
| Assets | $59.84MM | $90.93MM | $14.55MM |
| Operating Cash Flow | $-26.87MM | $-24.92MM | $-14.84MM |
| Capital expenditure | $7.87MM | $12.42MM | $2.10MM |
| Investing Cash Flow | $-12.38MM | $-14.13MM | $-3.71MM |
| Financing Cash Flow | $-0.11MM | $39.58MM | $13.62MM |
| Earnings Per Share** | $-0.74 | $-0.59 | $-1.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.